Jefferies Group’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
$350K Buy
19,510
+18,851
+2,861% +$247K ﹤0.01% 1174
2022
Q2
$6.34K Sell
659
-2,012
-75% -$25.3K ﹤0.01% 1480
2022
Q1
$45K Buy
+2,671
New +$39.5K ﹤0.01% 1412
2021
Q4
Sell
-58,115
Closed -$944K 2109
2021
Q3
$944K Sell
58,115
-191,885
-77% -$2.09M 0.01% 1015
2021
Q2
$1.58M Buy
+250,000
New +$1.61M 0.01% 832
2016
Q4
Sell
-22,170
Closed -$658K 2565
2016
Q3
$1.02M Sell
22,170
-8,104
-27% -$457K 0.01% 1272
2016
Q2
$1.54M Buy
+30,274
New +$1.5M 0.01% 982
2015
Q3
Sell
-73
Closed -$4K 3224
2015
Q2
$4K Buy
+73
New +$3.63K ﹤0.01% 3047

Other funds holding ISEE

Jefferies Group's ISEE Position: Q3 2022 in Review

Jefferies Group increased its IVERIC bio, Inc. Common Stock (ISEE) stake by 2,861% in Q3 2022, buying an estimated $247K and bringing the position to 19,510 shares worth $350K. The position accounts for ﹤0.01% of the portfolio, ranked #1174.

Jefferies Group first reported a position in ISEE in Q2 2015 and has held it in 8 quarters since. The position peaked at $1.58M in Q2 2021. 213 funds tracked by Wall St. Rank hold ISEE as of Q3 2022.

  • Jefferies Group held 19,510 shares of IVERIC bio, Inc. Common Stock worth $350K as of Q3 2022.
  • Jefferies Group bought 18,851 IVERIC bio, Inc. Common Stock shares in Q3 2022, an estimated $247K.
  • IVERIC bio, Inc. Common Stock made up ﹤0.01% of Jefferies Group's portfolio in Q3 2022, its #1174 holding.
  • Jefferies Group first reported a position in IVERIC bio, Inc. Common Stock in Q2 2015 and has held it in 8 quarters since.
  • Jefferies Group's IVERIC bio, Inc. Common Stock position peaked at $1.58M in Q2 2021.
  • 213 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q3 2022.

Based on Jefferies Group's 13F filing for Q3 2022, filed 14 Nov 2022.